Li, Qing Kay
Hu, Yingwei
Chen, Lijun
Schnaubelt, Michael
Cui Zhou, Daniel
Li, Yize
Lu, Rita Jui-Hsien
Thiagarajan, Mathangi
Hostetter, Galen
Newton, Chelsea J.
Jewell, Scott D.
Omenn, Gil
Robles, Ana I.
Mesri, Mehdi
Bathe, Oliver F.
Zhang, Bing
Ding, Li
Hruban, Ralph H.
Chan, Daniel W.
Zhang, Hui
Funding for this research was provided by:
National Cancer Institute (U24CA210985, U24CA210985, U24CA210985, U24CA210985, U24CA210985, U24CA210985, U24CA210985)
Article History
Received: 3 May 2022
Accepted: 26 September 2022
First Online: 20 October 2022
Declarations
:
: These criteria are followed by the guidelines of the Cancer Clinical Proteomics Research, National Cancer Institute [CitationRef removed]
: This manuscript has been read and approved by all the authors to publish and is not submitted or under consideration for publication elsewhere.
: The authors declare no competing interests.